Sphingolipids and lysosomal pathologies

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 5, 2014, Pages 799-810

  Schulze, Heike ^a   Sandhoff, Konrad ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Lipid storage; Lysosomal lipids; Membrane degradation; Sphingolipid catabolism

Indexed keywords

CERAMIDE GLUCOSYLTRANSFERASE; CERAMIDE SYNTHASE 1; CERAMIDE SYNTHASE 2; CERAMIDE SYNTHASE 3; CERAMIDE SYNTHASE 6; CEREBROSIDE SULFOTRANSFERASE; ENZYME; GALACTOSYLCERAMIDE; GANGLIOSIDE; GANGLIOSIDE GM2; GANGLIOSIDE GM2 ACTIVATOR PROTEIN; GANGLIOSIDE GM3; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID; LACTOSYLCERAMIDE ALPHA2,3 SIALYLTRANSFERASE; MIGLUSTAT; OLIGOSACCHARIDE; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID; SPHINGOLIPID ACTIVATOR PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; SULFATIDE; UNCLASSIFIED DRUG;

AUTONOMIC NEUROPATHY; AUTOPHAGY; CELL MEMBRANE; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENZYME REPLACEMENT; FABRY DISEASE; FARBER DISEASE; GAUCHER DISEASE; GENE MUTATION; GLOBOID CELL LEUKODYSTROPHY; GLYCOGEN STORAGE DISEASE TYPE 2; GLYCOSYLATION; GM1 GANGLIOSIDOSIS; GM2 GANGLIOSIDOSIS; GOLGI COMPLEX; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE I; HEREDITARY SENSORY NEUROPATHY TYPE I; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; ICHTHYOSIS; INFANTILE ONSET SYMPTOMATIC EPILEPSY SYNDROME; KEARNS SAYRE SYNDROME; LIPID DEGRADATION; LIPIDOSIS; LIPOGENESIS; LYSOSOME STORAGE DISEASE; METACHROMATIC LEUKODYSTROPHY; MUCOLIPIDOSIS; MUCOPOLYSACCHARIDOSIS; MUCOPOLYSACCHARIDOSIS TYPE 7; NIEMANN PICK DISEASE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY; SYMPTOMATIC EPILEPSY; TAY SACHS DISEASE; TRANS GOLGI NETWORK;

LIPID STORAGE; LYSOSOMAL LIPIDS; MEMBRANE DEGRADATION; SPHINGOLIPID CATABOLISM;

ANIMALS; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; SPHINGOLIPID ACTIVATOR PROTEINS; SPHINGOLIPIDS;

EID: 84897954529     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.10.015     Document Type: Review

References (201)

1. K. Sandhoff, T. Kolter, and K. Harzer Sphingolipid activator proteins C.R. Scriver, W.S. Sly, D. Valle, The Metabolic and Molecular Bases of Inherited Disease vol. III 2001 McGraw-Hill New York 3371 3388
2. H. Sakuraba, M. Sawada, F. Matsuzawa, S. Aikawa, Y. Chiba, Y. Jigami, and K. Itoh Molecular pathologies of and enzyme replacement therapies for lysosomal diseases CNS Neurol. Disord. Drug Targets 5 2006 401 413 (Pubitemid 44203351)
3. E.B. Vitner, F.M. Platt, and A.H. Futerman Common and uncommon pathogenic cascades in lysosomal storage diseases J. Biol. Chem. 285 2010 20423 20427
4. J.M. Aerts, C. Hollak, R. Boot, and A. Groener Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention Philos. Trans. R. Soc. Lond. B Biol. Sci. 358 2003 905 914 (Pubitemid 36639715)
5. L. Ginzburg, Y. Kacher, and A.H. Futerman The pathogenesis of glycosphingolipid storage disorders Semin. Cell Dev. Biol. 15 2004 417 431 (Pubitemid 38781904)
6. T. Kolter, and K. Sandhoff Sphingolipid metabolism diseases Biochim. Biophys. Acta 1758 2006 2057 2079 (Pubitemid 44879358)
7. Lysosomal disorders C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle The Metabolic and Molecular Bases of Inherited Disease 2001 Mc Graw-Hill New York
8. R. Kannagi, N.A. Cochran, F. Ishigami, S. Hakomori, P.W. Andrews, B.B. Knowles, and D. Solter Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells EMBO J. 2 1983 2355 2361
9. I. Eggens, B. Fenderson, T. Toyokuni, B. Dean, M. Stroud, and S. Hakomori Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells J. Biol. Chem. 264 1989 9476 9484 (Pubitemid 19157590)
10. G. van Echten, and K. Sandhoff Ganglioside metabolism. Enzymology, topology, and regulation J. Biol. Chem. 268 1993 5341 5344 (Pubitemid 23090844)
11. R.K. Yu, Y.T. Tsai, T. Ariga, and M. Yanagisawa Structures, biosynthesis, and functions of gangliosides - an overview J. Oleo Sci. 60 2011 537 544
12. L.N. Marekov, and P.M. Steinert Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope J. Biol. Chem. 273 1998 17763 17770 (Pubitemid 28355119)
13. R. Sandhoff Very long chain sphingolipids: tissue expression, function and synthesis FEBS Lett. 584 2010 1907 1913
14. B. Breiden, and K. Sandhoff The role of sphingolipid metabolism in cutaneous permeabilitybarrier formation Biochim. Biophys. Acta 2013 10.1016/j.bbalip.2013.08.010 (accepted article preview online August 15, 2013)
15. M. Levy, and A.H. Futerman Mammalian ceramide synthases IUBMB Life 62 2010 347 356
16. A.H. Merrill Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway J. Biol. Chem. 277 2002 25843 25846 (Pubitemid 34967059)
17. C. Ginkel, D. Hartmann, K. vom Dorp, A. Zlomuzica, H. Farwanah, M. Eckhardt, R. Sandhoff, J. Degen, M. Rabionet, E. Dere, P. Dormann, K. Sandhoff, and K. Willecke Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes J. Biol. Chem. 287 2012 41888 41902
18. K. Hanada, K. Kumagai, S. Yasuda, Y. Miura, M. Kawano, M. Fukasawa, and M. Nishijima Molecular machinery for non-vesicular trafficking of ceramide Nature 426 2003 803 809 (Pubitemid 38056858)
19. H. Lannert, C. Bunning, D. Jeckel, and F.T. Wieland Lactosylceramide is synthesized in the lumen of the Golgi apparatus FEBS Lett. 342 1994 91 96 (Pubitemid 24101400)
20. M.F. De Rosa, D. Sillence, C. Ackerley, and C. Lingwood Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis J. Biol. Chem. 279 2004 7867 7876 (Pubitemid 38294673)
21. P.D. Eckford, and F.J. Sharom The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids Biochem. J. 389 2005 517 526 (Pubitemid 41021155)
22. D. Halter, S. Neumann, S.M. van Dijk, J. Wolthoorn, A.M. de Maziere, O.V. Vieira, P. Mattjus, J. Klumperman, G. van Meer, and H. Sprong Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis J. Cell Biol. 179 2007 101 115 (Pubitemid 47606687)
23. G. D'Angelo, T. Uemura, C.C. Chuang, E. Polishchuk, M. Santoro, H. Ohvo-Rekila, T. Sato, G. Di Tullio, A. Varriale, S. D'Auria, T. Daniele, F. Capuani, L. Johannes, P. Mattjus, M. Monti, P. Pucci, R.L. Williams, J.E. Burke, F.M. Platt, A. Harada, and M.A. De Matteis Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi Nature 501 2013 116 120
24. F.G. Tafesse, K. Huitema, M. Hermansson, S. van der Poel, J. van den Dikkenberg, A. Uphoff, P. Somerharju, and J.C. Holthuis Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells J. Biol. Chem. 282 2007 17537 17547 (Pubitemid 47100300)
25. B.K. Gillard, R.G. Clement, and D.M. Marcus Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways Glycobiology 8 1998 885 890 (Pubitemid 28398985)
26. G. Tettamanti, R. Bassi, P. Viani, and L. Riboni Salvage pathways in glycosphingolipid metabolism Biochimie 85 2003 423 437 (Pubitemid 36626013)
27. R.L. Proia Glycosphingolipid functions: insights from engineered mouse models Philos. Trans. R. Soc. Lond. B Biol. Sci. 358 2003 879 883 (Pubitemid 36639712)
28. T. Kolter, R.L. Proia, and K. Sandhoff Combinatorial ganglioside biosynthesis J. Biol. Chem. 277 2002 25859 25862 (Pubitemid 34967063)
29. M.A. Simpson, H. Cross, C. Proukakis, D.A. Priestman, D.C. Neville, G. Reinkensmeier, H. Wang, M. Wiznitzer, K. Gurtz, A. Verganelaki, A. Pryde, M.A. Patton, R.A. Dwek, T.D. Butters, F.M. Platt, and A.H. Crosby Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase Nat. Genet. 36 2004 1225 1229 (Pubitemid 41288973)
30. A. Boukhris, R. Schule, J.L. Loureiro, C.M. Lourenco, E. Mundwiller, M.A. Gonzalez, P. Charles, J. Gauthier, I. Rekik, R.F. Acosta Lebrigio, M. Gaussen, F. Speziani, A. Ferbert, I. Feki, A. Caballero-Oteyza, A. Dionne-Laporte, M. Amri, A. Noreau, S. Forlani, V.T. Cruz, F. Mochel, P. Coutinho, P. Dion, C. Mhiri, L. Schols, J. Pouget, F. Darios, G.A. Rouleau, W. Marques Jr., A. Brice, A. Durr, S. Zuchner, and G. Stevanin Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia Am. J. Hum. Genet. 93 2013 118 123
31. K. Fragaki, S. Ait-El-Mkadem, A. Chaussenot, C. Gire, R. Mengual, L. Bonesso, M. Beneteau, J.E. Ricci, V. Desquiret-Dumas, V. Procaccio, A. Rotig, and V. Paquis-Flucklinger Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency Eur. J. Hum. Genet. 21 2013 528 534
32. A. Penno, M.M. Reilly, H. Houlden, M. Laura, K. Rentsch, V. Niederkofler, E.T. Stoeckli, G. Nicholson, F. Eichler, R.H. Brown Jr., A. von Eckardstein, and T. Hornemann Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids J. Biol. Chem. 285 2010 11178 11187
33. J.L. Dawkins, D.J. Hulme, S.B. Brahmbhatt, M. Auer-Grumbach, and G.A. Nicholson Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I Nat. Genet. 27 2001 309 312 (Pubitemid 32201853)
34. O. Florey, and M. Overholtzer Autophagy proteins in macroendocytic engulfment Trends Cell Biol. 22 2012 374 380
35. C. Settembre, C. Di Malta, V.A. Polito, M. Garcia Arencibia, F. Vetrini, S. Erdin, S.U. Erdin, T. Huynh, D. Medina, P. Colella, M. Sardiello, D.C. Rubinsztein, and A. Ballabio TFEB links autophagy to lysosomal biogenesis Science 332 2011 1429 1433
36. P. Delves, S. Martin, D. Burton, and I. Roit Roit's Essential Immunology 11th ed. 2006 Blackwell Publishing Malden, MA
37. G.J. Doherty, and H.T. McMahon Mechanisms of endocytosis Annu. Rev. Biochem. 78 2009 857 902
38. J.K. Burkhardt, S. Hüttler, A. Klein, W. Möbius, A. Habermann, G. Griffiths, and K. Sandhoff Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor Eur. J. Cell Biol. 73 1997 10 18 (Pubitemid 27226186)
39. W. Möbius, V. Herzog, K. Sandhoff, and G. Schwarzmann Intracellular distribution of a biotin-labeled ganglioside, GM1, by immunoelectron microscopy after endocytosis in fibroblasts J. Histochem. Cytochem. 47 1999 1005 1014 (Pubitemid 29379899)
40. W. Fürst, and K. Sandhoff Activator proteins and topology of lysosomal sphingolipid catabolism Biochim. Biophys. Acta 1126 1992 1 16
41. T. Wollert, and J.H. Hurley Molecular mechanism of multivesicular body biogenesis by ESCRT complexes Nature 464 2010 864 869
42. T. Kolter, and K. Sandhoff Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids Annu. Rev. Cell Dev. Biol. 21 2005 81 103 (Pubitemid 41740628)
43. H.D. Gallala, B. Breiden, and K. Sandhoff Regulation of the NPC2 protein-mediated cholesterol trafficking by membrane lipids J. Neurochem. 116 2011 702 707
44. M. Marsh, and G. van Meer Cell biology. No ESCRTs for exosomes Science 319 2008 1191 1192
45. S. Stuffers, C. Sem Wegner, H. Stenmark, and A. Brech Multivesicular endosome biogenesis in the absence of ESCRTs Traffic 10 2009 925 937
46. Z. Xu, W. Farver, and J. Storch Regulation of sterol transport between membranes and NPC2 Biochemistry 47 2008 11134 11143
47. E.D. Carstea, J.A. Morris, K.G. Coleman, S.K. Loftus, D. Zhang, C. Cummings, J. Gu, M.A. Rosenfeld, W.J. Pavan, D.B. Krizman, J. Nagle, M.H. Polymeropoulos, S.L. Sturley, Y.A. Ioannou, M.E. Higgins, M. Comly, A. Cooney, A. Brown, C.R. Kaneski, E.J. Blanchette-Mackie, N.K. Dwyer, E.B. Neufeld, T.Y. Chang, L. Liscum, J.F. Strauss III, K. Ohno, M. Zeigler, R. Carmi, J. Sokol, D. Markie, R.R. O'Neill, O.P. van Diggelen, M. Elleder, M.C. Patterson, R.O. Brady, M.T. Vanier, P.G. Pentchev, and D.A. Tagle Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis Science 277 1997 228 231 (Pubitemid 27446076)
48. S. Naureckiene, D.E. Sleat, H. Lackland, A. Fensom, M.T. Vanier, R. Wattiaux, M. Jadot, and P. Lobel Identification of HE1 as the second gene of Niemann-Pick C disease Science 290 2000 2298 2301 (Pubitemid 32041569)
49. R.E. Infante, M.L. Wang, A. Radhakrishnan, H.J. Kwon, M.S. Brown, and J.L. Goldstein NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes Proc. Natl. Acad. Sci. U. S. A. 105 2008 15287 15292
50. H.J. Kwon, L. Abi-Mosleh, M.L. Wang, J. Deisenhofer, J.L. Goldstein, M.S. Brown, and R.E. Infante Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol Cell 137 2009 1213 1224
51. J.E. Vance, and K.B. Peake Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin Curr. Opin. Lipidol. 22 2011 204 209
52. S. Locatelli-Hoops, N. Remmel, R. Klingenstein, B. Breiden, M. Rossocha, M. Schöniger, C. Königs, W. Saenger, and K. Sandhoff Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate- containing membranes: patient variant Saposin A lacks lipid extraction capacity J. Biol. Chem. 281 2006 32451 32460 (Pubitemid 46036800)
53. N. Remmel, S. Locatelli-Hoops, B. Breiden, G. Schwarzmann, and K. Sandhoff Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity FEBS J. 274 2007 3405 3420 (Pubitemid 47024974)
54. J. Storch, and Z. Xu Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking Biochim. Biophys. Acta 1791 2009 671 678
55. M. Abdul-Hammed, B. Breiden, M.A. Adebayo, J.O. Babalola, G. Schwarzmann, and K. Sandhoff Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion J. Lipid Res. 51 2010 1747 1760
56. V.O. Oninla, B. Breiden, J.O. Babalola, K. Sandhoff, in preparation, (2013).
57. M.T. Vanier Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen Biochim. Biophys. Acta 750 1983 178 184 (Pubitemid 13184757)
58. H. Gallala, and K. Sandhoff Biological function of the cellular lipid BMP - BMP as a key activator for cholesterol sorting and membrane digestion Neurochem. Res. 36 2011 1594 1600
59. E.L. Eskelinen, Y. Tanaka, and P. Saftig At the acidic edge: emerging functions for lysosomal membrane proteins Trends Cell Biol. 13 2003 137 145 (Pubitemid 36293786)
60. M. Schwake, B. Schroder, and P. Saftig Lysosomal membrane proteins and their central role in physiology Traffic 14 2013 739 748
61. E.D. Hay Cell Biology of Extracellular Matrix 1989 Plenum Press New York
62. H. Appelqvist, L. Sandin, K. Bjornstrom, P. Saftig, B. Garner, K. Ollinger, and K. Kagedal Sensitivity to lysosome-dependent cell death is directly regulated by lysosomal cholesterol content PLoS One 7 2012 e50262
63. T. Kirkegaard, A.G. Roth, N.H.T. Petersen, A.K. Mahalka, O.D. Olsen, I. Moilanen, A. Zylicz, J. Knudsen, K. Sandhoff, C. Arenz, P.K.J. Kinnunen, J. Nylandsted, and M. Jaattela Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology Nature 463 2010 549 553
64. A. Giehl, T. Lemm, O. Bartelsen, K. Sandhoff, and A. Blume Interaction of the GM2-activator protein with phospholipid-ganglioside bilayer membranes and with monolayers at the air-water interface Eur. J. Biochem. 261 1999 650 658 (Pubitemid 29226061)
65. N. Werth, C.G. Schuette, G. Wilkening, T. Lemm, and K. Sandhoff Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids J. Biol. Chem. 276 2001 12685 12690
66. G. Wilkening, T. Linke, and K. Sandhoff Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators J. Biol. Chem. 273 1998 30271 30278 (Pubitemid 28545494)
67. T. Linke, G. Wilkening, F. Sadeghlar, H. Mozcall, K. Bernardo, E. Schuchman, and K. Sandhoff Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins J. Biol. Chem. 276 2001 5760 5768
68. E. Conzelmann, and K. Sandhoff AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2 Proc. Natl. Acad. Sci. U. S. A. 75 1978 3979 3983 (Pubitemid 8399855)
69. G. Vielhaber, R. Hurwitz, and K. Sandhoff Biosynthesis, processing, and targeting of sphingolipid activator protein (SAP)precursor in cultured human fibroblasts. Mannose 6-phosphate receptor-independent endocytosis of SAP precursor J. Biol. Chem. 271 1996 32438 32446 (Pubitemid 26422287)
70. M. Hiraiwa, B.M. Martin, Y. Kishimoto, G.E. Conner, S. Tsuji, and J.S. O'Brien Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside Arch. Biochem. Biophys. 341 1997 17 24 (Pubitemid 27198026)
71. R. Spiegel, G. Bach, V. Sury, G. Mengistu, B. Meidan, S. Shalev, Y. Shneor, H. Mandel, and M. Zeigler A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans Mol. Genet. Metab. 84 2005 160 166 (Pubitemid 40164576)
72. R.L. Stevens, A.L. Fluharty, H. Kihara, M.M. Kaback, L.J. Shapiro, B. Marsh, K. Sandhoff, and G. Fischer Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy Am. J. Hum. Genet. 33 1981 900 906 (Pubitemid 12194877)
73. K.A. Kretz, G.S. Carson, S. Morimoto, Y. Kishimoto, A.L. Fluharty, and J.S. O'Brien Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect Proc. Natl. Acad. Sci. U. S. A. 87 1990 2541 2544
74. H. Christomanou, A. Aignesberger, and R.P. Linke Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant Biol. Chem. Hoppe Seyler 367 1986 879 890
75. A. Diaz-Font, B. Cormand, R. Santamaria, L. Vilageliu, D. Grinberg, and A. Chabas A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity Hum. Genet. 117 2005 275 277 (Pubitemid 43136805)
76. K. Sandhoff My journey into the world of sphingolipids and sphingolipidoses Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 88 2012 554 582
77. T. Doering, W.M. Holleran, A. Potratz, G. Vielhaber, P.M. Elias, K. Suzuki, and K. Sandhoff Sphingolipid activator proteins are required for epidermal permeability barrier formation J. Biol. Chem. 274 1999 11038 11045
78. C.G. Schütte, B. Pierstorff, S. Hüttler, and K. Sandhoff Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis Glycobiology 11 2001 81R 90R (Pubitemid 32655236)
79. W.M. Holleran, E.I. Ginns, G.K. Menon, J.U. Grundmann, M. Fartasch, C.E. McKinney, P.M. Elias, and E. Sidransky Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease J. Clin. Invest. 93 1994 1756 1764
80. Y. Liu, K. Suzuki, J.D. Reed, A. Grinberg, H. Westphal, A. Hoffmann, T. Doring, K. Sandhoff, and R.L. Proia Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure Proc. Natl. Acad. Sci. U. S. A. 95 1998 2503 2508 (Pubitemid 28145971)
81. T. Doering, R.L. Proia, and K. Sandhoff Accumulation of protein-bound epidermal glucosylceramides in beta-glucocerebrosidase deficient type 2 Gaucher mice FEBS Lett. 447 1999 167 170 (Pubitemid 29146079)
82. M.C. Patterson Gangliosidoses Handb. Clin. Neurol. 113 2013 1707 1708
83. K. Sandhoff, and K. Harzer Gangliosides and gangliosidoses, Principles of molecular and metabolic pathogenesis J. Neurosci. 33 2013 10195 10208
84. M. Kölzer, N. Werth, and K. Sandhoff Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine FEBS Lett. 559 2004 96 98 (Pubitemid 38186710)
85. R. Hurwitz, K. Ferlinz, and K. Sandhoff The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts Biol. Chem. Hoppe Seyler 375 1994 447 450 (Pubitemid 2120332)
86. H. Jatzkewitz, and K. Sandhoff On a biochemically special form of infantile amaturotic idiocy Biochim. Biophys. Acta 70 1963 354 356
87. S. Okada, and J.S. O'Brien Generalized gangliosidosis: beta-galactosidase deficiency Science 160 1968 1002 1004
88. G. Wilkening, T. Linke, G. Uhlhorn-Dierks, and K. Sandhoff Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP J. Biol. Chem. 275 2000 35814 35819
89. A. d'Azzo, G. Andria, P. Strisciuglio, and G.H. Galactosialidosis C.R. Scriver, A.L. Beaudet, W.S. Sly, V. D. The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw-Hill New York 3811 3826
90. A.V. Pshezhetsky, and M. Ashmarina Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology Prog. Nucleic Acid Res. Mol. Biol. 69 2001 81 114
91. E.F. Neufeld, and J. Muenzer The mucopolysaccharidoses C.R. Scriver, A.L. Beaudet, W.S. Sly, V. D. The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw-Hill New York 3421 3452
92. T. Okumiya, H. Sakuraba, R. Kase, and T. Sugiura Imbalanced substrate specificity of mutant beta-galactosidase in patients with Morquio B disease Mol. Genet. Metab. 78 2003 51 58 (Pubitemid 36268742)
93. M.J. Lemieux, B.L. Mark, M.M. Cherney, S.G. Withers, D.J. Mahuran, and M.N. James Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis J. Mol. Biol. 359 2006 913 929 (Pubitemid 43831920)
94. H.J. Kytzia, and K. Sandhoff Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A J. Biol. Chem. 260 1985 7568 7572 (Pubitemid 15063038)
95. T. Maier, N. Strater, C.G. Schütte, R. Klingenstein, K. Sandhoff, and W. Saenger The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease J. Mol. Biol. 328 2003 669 681 (Pubitemid 36438580)
96. S.T. Hepbildikler, R. Sandhoff, M. Kölzer, R.L. Proia, and K. Sandhoff Physiological substrates for human lysosomal beta-hexosaminidase S J. Biol. Chem. 277 2002 2562 2572 (Pubitemid 34953280)
97. H.J. Kytzia, U. Hinrichs, I. Maire, K. Suzuki, and K. Sandhoff Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity EMBO J. 2 1983 1201 1205
98. K. Sandhoff, U. Andreae, and H. Jatzkewitz Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs Pathol. Eur. 3 1968 278 285
99. K. Suzuki, K. Sango, R.L. Proia, and C. Langaman Mice deficient in all forms of lysosomal beta-hexosaminidase show mucopolysaccharidosis-like pathology J. Neuropathol. Exp. Neurol. 56 1997 693 703 (Pubitemid 27463104)
100. A. Rolfs, T. Bottcher, M. Zschiesche, P. Morris, B. Winchester, P. Bauer, U. Walter, E. Mix, M. Lohr, K. Harzer, U. Strauss, J. Pahnke, A. Grossmann, and R. Benecke Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study Lancet 366 2005 1794 1796 (Pubitemid 41642643)
101. I.Y., and R.J. Desnick α-Galactosidase A deficiency fabry disease B.A. C.R. Scriver, W.S. Sly, D. Valle, The Metabolic and Molecular Bases of inherited Disease 2001 McGraw-Hill New York 3733 3774
102. G.G., and E. Beutler Gaucher disease B.A. C. Scriver, W.S. Sly, D. Valle, The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw-Hill New York 3635 3668
103. R.O. Brady, J.N. Kanfer, and D. Shapiro Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease Biochem. Biophys. Res. Commun. 18 1965 221 225
104. A.D. Patrick Short communications: a deficiency of glucocerebrosidase in Gaucher's disease Biochem. J. 97 1965 17C 18C
105. F. Sarmientos, G. Schwarzmann, and K. Sandhoff Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system Eur. J. Biochem. 160 1986 527 535 (Pubitemid 17044425)
106. O. Nilsson, and L. Svennerholm Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease J. Neurochem. 39 1982 709 718 (Pubitemid 12034962)
107. O. Nilsson, J.E. Mansson, G. Hakansson, and L. Svennerholm The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease Biochim. Biophys. Acta 712 1982 453 463 (Pubitemid 13198976)
108. T. Pampols, M. Pineda, M.L. Giros, I. Ferrer, V. Cusi, A. Chabas, F.X. Sanmarti, M.T. Vanier, and H. Christomanou Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant Acta Neuropathol. 97 1999 91 97 (Pubitemid 29132651)
109. A.M. Vaccaro, M. Motta, M. Tatti, S. Scarpa, L. Masuelli, M. Bhat, M.T. Vanier, A. Tylki-Szymanska, and R. Salvioli Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting Hum. Mol. Genet. 19 2010 2987 2997
110. N. Dekker, L. van Dussen, C.E. Hollak, H. Overkleeft, S. Scheij, K. Ghauharali, M.J. van Breemen, M.J. Ferraz, J.E. Groener, M. Maas, F.A. Wijburg, D. Speijer, A. Tylki-Szymanska, P.K. Mistry, R.G. Boot, and J.M. Aerts Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response Blood 118 2011 e118 e127
111. E. Sidransky, M. Fartasch, R.E. Lee, L.A. Metlay, S. Abella, A. Zimran, W. Gao, P.M. Elias, E.I. Ginns, and W.M. Holleran Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease Pediatr. Res. 39 1996 134 141 (Pubitemid 26003533)
112. M.A. Nalls, R. Duran, G. Lopez, M. Kurzawa-Akanbi, I.G. McKeith, P.F. Chinnery, C.M. Morris, J. Theuns, D. Crosiers, P. Cras, S. Engelborghs, P.P. De Deyn, C. Van Broeckhoven, D.M. Mann, J. Snowden, S. Pickering-Brown, N. Halliwell, Y. Davidson, L. Gibbons, J. Harris, U.M. Sheerin, J. Bras, J. Hardy, L. Clark, K. Marder, L.S. Honig, D. Berg, W. Maetzler, K. Brockmann, T. Gasser, F. Novellino, A. Quattrone, G. Annesi, E.V. De Marco, E. Rogaeva, M. Masellis, S.E. Black, J.M. Bilbao, T. Foroud, B. Ghetti, W.C. Nichols, N. Pankratz, G. Halliday, S. Lesage, S. Klebe, A. Durr, C. Duyckaerts, A. Brice, B.I. Giasson, J.Q. Trojanowski, H.I. Hurtig, N. Tayebi, C. Landazabal, M.A. Knight, M. Keller, A.B. Singleton, T.G. Wolfsberg, and E. Sidransky A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies JAMA Neurol. 70 2013 727 735
113. T.L. Yap, A. Velayati, E. Sidransky, and J.C. Lee Membrane-bound alpha-synuclein interacts with glucocerebrosidase and inhibits enzyme activity Mol. Genet. Metab. 108 2013 56 64
114. T.L. Yap, J.M. Gruschus, A. Velayati, E. Sidransky, and J.C. Lee Saposin C protects glucocerebrosidase against alpha-synuclein inhibition Biochemistry 52 2013 7161 7163
115. D. Reczek, M. Schwake, J. Schroder, H. Hughes, J. Blanz, X. Jin, W. Brondyk, S. Van Patten, T. Edmunds, and P. Saftig LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase Cell 131 2007 770 783 (Pubitemid 350087202)
116. L. Svennerholm, M.T. Vanier, and J.E. Mansson Krabbe disease: a galactosylsphingosine (psychosine) lipidosis J. Lipid Res. 21 1980 53 64 (Pubitemid 10120438)
117. S. Neuenhofer, E. Conzelmann, G. Schwarzmann, H. Egge, and K. Sandhoff Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain Biol. Chem. Hoppe Seyler 367 1986 241 244 (Pubitemid 16137509)
118. J.M. Aerts, J.E. Groener, S. Kuiper, W.E. Donker-Koopman, A. Strijland, R. Ottenhoff, C. van Roomen, M. Mirzaian, F.A. Wijburg, G.E. Linthorst, A.C. Vedder, S.M. Rombach, J. Cox-Brinkman, P. Somerharju, R.G. Boot, C.E. Hollak, R.O. Brady, and B.J. Poorthuis Elevated globotriaosylsphingosine is a hallmark of Fabry disease Proc. Natl. Acad. Sci. U. S. A. 105 2008 2812 2817 (Pubitemid 351723626)
119. K. Suzuki Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status Neurochem. Res. 23 1998 251 259
120. V. Gieselmann, S. Franken, D. Klein, J.E. Mansson, R. Sandhoff, R. Lullmann Rauch, D. Hartmann, V.P. Saravanan, P.P. De Deyn, R. D'Hooge, A.M. Van Der Linden, and N. Schaeren-Wiemers Metachromatic leukodystrophy: consequences of sulphatide accumulation Acta Paediatr. Suppl. 92 2003 74 79 (discussion 45) (Pubitemid 38134754)
121. E. Mehl, and H. Jatzkewitz Eine Cerebrosidsulfatase aus Schweineniere Hoppe Seylers Z. Physiol. Chem. 339 1964 260 276
122. W. Mraz, G. Fischer, and H. Jatzkewitz Low molecular weight proteins in secondary lysosomes as activators of different sphingolipid hydrolases FEBS Lett. 67 1976 104 109
123. S. Gartner, E. Conzelmann, and K. Sandhoff Activator protein for the degradation of globotriaosylceramide by human alpha-galactosidase J. Biol. Chem. 258 1983 12378 12385 (Pubitemid 14231163)
124. Y. Sun, D.P. Witte, H. Ran, M. Zamzow, S. Barnes, H. Cheng, X. Han, M.T. Williams, M.R. Skelton, C.V. Vorhees, and G.A. Grabowski Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice Hum. Mol. Genet. 17 2008 2345 2356
125. S.C. Li, S. Sonnino, G. Tettamanti, and Y.T. Li Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids J. Biol. Chem. 263 1988 6588 6591
126. K. Suzuki, and Y. Suzuki Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase Proc. Natl. Acad. Sci. U. S. A. 66 1970 302 309
127. D.A. Wenger, K. Suzuki, Y. Suzuki, and K. Suzuki Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease) C.R. Scriver, A.L. Beaudet, W.S. Sly, V. D. The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw-Hill New York
128. K. Harzer, B.C. Paton, H. Christomanou, M. Chatelut, T. Levade, M. Hiraiwa, and J.S. O'Brien Saposins (sap) A and C activate the degradation of galactosylceramide in living cells FEBS Lett. 417 1997 270 274 (Pubitemid 27511602)
129. E.H. Schuchman, and R.J. Desnick Niemann-Pick disease types A B: acid sphingomyelinase deficiencies C.R. Scriver, A.L. Beaudet, W.S. Sly, V. D. The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw-Hill New York 3589 3610
130. E.H. Schuchman The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease Int. J. Clin. Pharmacol. Ther. 47 Suppl. 1 2009 S48 S57
131. L.E. Quintern, G. Weitz, H. Nehrkorn, J.M. Tager, A.W. Schram, and K. Sandhoff Acid sphingomyelinase from human urine: purification and characterization Biochim. Biophys. Acta 922 1987 323 336 (Pubitemid 18014812)
132. Y.H. Zeidan, and Y.A. Hannun The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation Curr. Mol. Med. 10 2010 454 466
133. S. Lansmann, C.G. Schütte, O. Bartelsen, J. Hörnschemeyer, T. Linke, J. Weisgerber, and K. Sandhoff Human acid sphingomyelinase Eur. J. Biochem. 270 2003 1076 1088
134. D. Graber, R. Salvayre, and T. Levade Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells J. Neurochem. 63 1994 1060 1068 (Pubitemid 24266620)
135. T. Linke, G. Wilkening, S. Lansmann, H. Moczall, O. Bartelsen, J. Weisgerber, and K. Sandhoff Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins Biol. Chem. 382 2001 283 290 (Pubitemid 32243936)
136. E. Gulbins, and P.L. Li Physiological and pathophysiological aspects of ceramide Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 2006 R11 R26
137. S. Spiegel, and S. Milstien Sphingosine 1-phosphate, a key cell signaling molecule J. Biol. Chem. 277 2002 25851 25854 (Pubitemid 34967061)
138. J. Kornhuber, A. Medlin, S. Bleich, V. Jendrossek, A.W. Henkel, J. Wiltfang, and E. Gulbins High activity of acid sphingomyelinase in major depression J. Neural Transm. 112 2005 1583 1590 (Pubitemid 41504272)
139. X. He, Y. Huang, B. Li, C.X. Gong, and E.H. Schuchman Deregulation of sphingolipid metabolism in Alzheimer's disease Neurobiol. Aging 31 2010 398 408
140. M. Reichel, J. Beck, C. Muhle, A. Rotter, S. Bleich, E. Gulbins, and J. Kornhuber Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients Alcohol. Clin. Exp. Res. 35 2011 1852 1859
141. R. Savic, X. He, I. Fiel, and E.H. Schuchman Recombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancer PLoS One 8 2013 e65620
142. A. Klein, M. Henseler, C. Klein, K. Suzuki, K. Harzer, and K. Sandhoff Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo Biochem. Biophys. Res. Commun. 200 1994 1440 1448 (Pubitemid 24181813)
143. N. Okino, X. He, S. Gatt, K. Sandhoff, M. Ito, and E.H. Schuchman The reverse activity of human acid ceramidase J. Biol. Chem. 278 2003 29948 29953 (Pubitemid 36962383)
144. E. Eliyahu, J.H. Park, N. Shtraizent, X. He, and E.H. Schuchman Acid ceramidase is a novel factor required for early embryo survival FASEB J. 21 2007 1403 1409 (Pubitemid 46684843)
145. E. Eliyahu, N. Shtraizent, K. Martinuzzi, J. Barritt, X. He, H. Wei, S. Chaubal, A.B. Copperman, and E.H. Schuchman Acid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization FASEB J. 24 2010 1229 1238
146. H.J. Kytzia, U. Hinrichs, and K. Sandhoff Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates Hum. Genet. 67 1984 414 418 (Pubitemid 14047392)
147. P. Leinekugel, S. Michel, E. Conzelmann, and K. Sandhoff Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease Hum. Genet. 88 1992 513 523
148. R.O. Brady, P.G. Pentchev, A.E. Gal, S.R. Hibbert, and A.S. Dekaban Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease N. Engl. J. Med. 291 1974 989 993
149. N.W. Barton, R.O. Brady, J.M. Dambrosia, A.M. Di Bisceglie, S.H. Doppelt, S.C. Hill, H.J. Mankin, G.J. Murray, R.I. Parker, and C.E. Argoff et al. Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease N. Engl. J. Med. 324 1991 1464 1470
150. N.W. Barton, F.S. Furbish, G.J. Murray, M. Garfield, and R.O. Brady Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease Proc. Natl. Acad. Sci. U. S. A. 87 1990 1913 1916
151. R.J. Desnick, and E.H. Schuchman Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges Annu. Rev. Genomics Hum. Genet. 13 2012 307 335
152. C. Vogler, B. Levy, J.H. Grubb, N. Galvin, Y. Tan, E. Kakkis, N. Pavloff, and W.S. Sly Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII Proc. Natl. Acad. Sci. U. S. A. 102 2005 14777 14782 (Pubitemid 41457132)
153. U. Matzner, E. Herbst, K.K. Hedayati, R. Lullmann-Rauch, C. Wessig, S. Schroder, C. Eistrup, C. Moller, J. Fogh, and V. Gieselmann Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy Hum. Mol. Genet. 14 2005 1139 1152 (Pubitemid 40613903)
154. F. Weidemann, M. Niemann, S. Stork, F. Breunig, M. Beer, C. Sommer, S. Herrmann, G. Ertl, and C. Wanner Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications J. Intern. Med. 274 2013 331 341
155. R. Sano, I. Annunziata, A. Patterson, S. Moshiach, E. Gomero, J. Opferman, M. Forte, and A. d'Azzo GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2 +)-dependent mitochondrial apoptosis Mol. Cell 36 2009 500 511
156. F.M. Platt, and M. Jeyakumar Substrate reduction therapy Acta Paediatr. Suppl. 97 2008 88 93 (Pubitemid 351421298)
157. D. Elstein, A. Dweck, D. Attias, I. Hadas-Halpern, S. Zevin, G. Altarescu, J.F. Aerts, S. van Weely, and A. Zimran Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement Blood 110 2007 2296 2301 (Pubitemid 47523147)
158. R. Heitner, D. Elstein, J. Aerts, S. Weely, and A. Zimran Low-dose N-butyldeoxynojirimycin (OGT 918) for type I Gaucher disease Blood Cells Mol. Dis. 28 2002 127 133 (Pubitemid 34743745)
159. C. Ficicioglu Review of miglustat for clinical management in Gaucher disease type 1 Ther. Clin. Risk Manag. 4 2008 425 431 (Pubitemid 351712001)
160. J.Q. Fan A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity Biol. Chem. 389 2008 1 11
161. J.Q. Fan, S. Ishii, N. Asano, and Y. Suzuki Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor Nat. Med. 5 1999 112 115 (Pubitemid 29051008)
162. S. Ishii Pharmacological chaperone therapy for Fabry disease Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 88 2012 18 30
163. A.R. Sawkar, W.C. Cheng, E. Beutler, C.H. Wong, W.E. Balch, and J.W. Kelly Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease Proc. Natl. Acad. Sci. U. S. A. 99 2002 15428 15433 (Pubitemid 35403951)
164. J. Matsuda, O. Suzuki, A. Oshima, Y. Yamamoto, A. Noguchi, K. Takimoto, M. Itoh, Y. Matsuzaki, Y. Yasuda, S. Ogawa, Y. Sakata, E. Nanba, K. Higaki, Y. Ogawa, L. Tominaga, K. Ohno, H. Iwasaki, H. Watanabe, R.O. Brady, and Y. Suzuki Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis Proc. Natl. Acad. Sci. U. S. A. 100 2003 15912 15917 (Pubitemid 38021089)
165. M.B. Tropak, S.P. Reid, M. Guiral, S.G. Withers, and D. Mahuran Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients J. Biol. Chem. 279 2004 13478 13487 (Pubitemid 38468872)
166. M.S. Sands, and B.L. Davidson Gene therapy for lysosomal storage diseases Mol. Ther. 13 2006 839 849
167. I.B. Enquist, E. Nilsson, A. Ooka, J.E. Mansson, K. Olsson, M. Ehinger, R.O. Brady, J. Richter, and S. Karlsson Effective cell and gene therapy in a murine model of Gaucher disease Proc. Natl. Acad. Sci. U. S. A. 103 2006 13819 13824 (Pubitemid 44413991)
168. A. Biffi, A. Capotondo, S. Fasano, U. del Carro, S. Marchesini, H. Azuma, M.C. Malaguti, S. Amadio, R. Brambilla, M. Grompe, C. Bordignon, A. Quattrini, and L. Naldini Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice J. Clin. Invest. 116 2006 3070 3082 (Pubitemid 44684492)
169. M.B. Cachon-Gonzalez, S.Z. Wang, A. Lynch, R. Ziegler, S.H. Cheng, and T.M. Cox Effective gene therapy in an authentic model of Tay-Sachs-related diseases Proc. Natl. Acad. Sci. U. S. A. 103 2006 10373 10378 (Pubitemid 44051174)
170. K. Dobrenis Cell mediated delivery system W.S. F.M. Platt, Lysosomal Disorders of the Brain 2004 Oxford Univ. Press Inc. New York 339 380
171. W. Krivit Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases Springer Semin. Immunopathol. 26 2004 119 132 (Pubitemid 40021961)
172. W. Krivit, P. Aubourg, E. Shapiro, and C. Peters Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome Curr. Opin. Hematol. 6 1999 377 382 (Pubitemid 29503144)
173. W. Krivit, C. Peters, and E.G. Shapiro Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III Curr. Opin. Neurol. 12 1999 167 176 (Pubitemid 29209802)
174. L.S. Shihabuddin, S. Numan, M.R. Huff, J.C. Dodge, J. Clarke, S.L. Macauley, W. Yang, T.V. Taksir, G. Parsons, M.A. Passini, F.H. Gage, and G.R. Stewart Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology J. Neurosci. 24 2004 10642 10651 (Pubitemid 39557637)
175. M. Jeyakumar, J.P. Lee, N.R. Sibson, J.P. Lowe, D.J. Stuckey, K. Tester, G. Fu, R. Newlin, D.A. Smith, E.Y. Snyder, and F.M. Platt Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease Stem Cells 27 2009 2362 2370
176. H. Schulze, and K. Sandhoff Lysosomal lipid storage diseases Cold Spring Harb Perspect Biol 3 2011 pii: a004804. doi: 10.1101/cshperspect.a004804
177. M. Wendeler, J. Hörnschemeyer, D. Hoffmann, T. Kolter, G. Schwarzmann, and K. Sandhoff Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation Eur. J. Biochem. 271 2004 614 627 (Pubitemid 38183636)
178. L. Boccuto, K. Aoki, H. Flanagan-Steet, C.F. Chen, X. Fan, F. Bartel, M. Petukh, A. Pittman, R. Saul, A. Chaubey, E. Alexov, M. Tiemeyer, R. Steet, and C.E. Schwartz A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation Hum. Mol. Genet. 2013 10.1093/hmg/ddt434 (first published online: September 10, 2013)
179. F.P. Radner, S. Marrakchi, P. Kirchmeier, G.J. Kim, F. Ribierre, B. Kamoun, L. Abid, M. Leipoldt, H. Turki, W. Schempp, R. Heilig, M. Lathrop, and J. Fischer Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans PLoS Genet. 9 2013 e1003536
180. K.M. Eckl, R. Tidhar, H. Thiele, V. Oji, I. Hausser, S. Brodesser, M.L. Preil, A. Onal-Akan, F. Stock, D. Müller, K. Becker, R. Casper, G. Nürnberg, J. Altmüller, P. Nürnberg, H. Traupe, A.H. Futerman, and H.C. Hennies Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length J. Invest. Dermatol. 133 2013 2202 2211
181. M.R. Hojjati, Z. Li, and X.C. Jiang Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice Biochim. Biophys. Acta 1737 2005 44 51 (Pubitemid 41550382)
182. L. Zhao, S.D. Spassieva, T.J. Jucius, L.D. Shultz, H.E. Shick, W.B. Macklin, Y.A. Hannun, L.M. Obeid, and S.L. Ackerman A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation PLoS Genet. 7 2011 e1002063
183. Y. Pewzner-Jung, O. Brenner, S. Braun, E.L. Laviad, S. Ben-Dor, E. Feldmesser, S. Horn-Saban, D. Amann-Zalcenstein, C. Raanan, T. Berkutzki, R. Erez-Roman, O. Ben-David, M. Levy, D. Holzman, H. Park, A. Nyska, A.H. Merrill Jr., and A.H. Futerman A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy J. Biol. Chem. 285 2010 10911 10923
184. S. Imgrund, D. Hartmann, H. Farwanah, M. Eckhardt, R. Sandhoff, J. Degen, V. Gieselmann, K. Sandhoff, and K. Willecke Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas J. Biol. Chem. 284 2009 33549 33560
185. R. Jennemann, M. Rabionet, K. Gorgas, S. Epstein, A. Dalpke, U. Rothermel, A. Bayerle, F. van der Hoeven, S. Imgrund, J. Kirsch, W. Nickel, K. Willecke, H. Riezman, H.J. Gröne, and R. Sandhoff Loss of ceramide synthase 3 causes lethal skin barrier disruption Hum. Mol. Genet. 21 2012 586 608
186. P. Ebel, K. Vom Dorp, E. Petrasch-Parwez, A. Zlomuzica, K. Kinugawa, J. Mariani, D. Minich, C. Ginkel, J. Welcker, J. Degen, M. Eckhardt, E. Dere, P. Dörmann, and K. Willecke Inactivation of ceramide synthase 6 in mice results in an altered sphingolipid metabolism and behavioral abnormalities J. Biol. Chem. 288 2013 21433 21447
187. M.L. Allende, T. Sasaki, H. Kawai, A. Olivera, Y. Mi, G. van Echten-Deckert, R. Hajdu, M. Rosenbach, C.A. Keohane, S. Mandala, S. Spiegel, and R.L. Proia Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720 J. Biol. Chem. 279 2004 52487 52492 (Pubitemid 39656625)
188. K. Mizugishi, T. Yamashita, A. Olivera, G.F. Miller, S. Spiegel, and R.L. Proia Essential role for sphingosine kinases in neural and vascular development Mol. Cell. Biol. 25 2005 11113 11121 (Pubitemid 41747151)
189. K. Honke, Y. Hirahara, J. Dupree, K. Suzuki, B. Popko, K. Fukushima, J. Fukushima, T. Nagasawa, N. Yoshida, Y. Wada, and N. Taniguchi Paranodal junction formation and spermatogenesis require sulfoglycolipids Proc. Natl. Acad. Sci. U. S. A. 99 2002 4227 4232 (Pubitemid 34285968)
190. A. Bosio, E. Binczek, and W. Stoffel Molecular cloning and characterization of the mouse CGT gene encoding UDP-galactose ceramide-galactosyltransferase (cerebroside synthetase) Genomics 35 1996 223 226 (Pubitemid 26236171)
191. T. Coetzee, X. Li, N. Fujita, J. Marcus, K. Suzuki, U. Francke, and B. Popko Molecular cloning, chromosomal mapping, and characterization of the mouse UDP-galactose:ceramide galactosyltransferase gene Genomics 35 1996 215 222 (Pubitemid 26236170)
192. T. Yamashita, R. Wada, T. Sasaki, C. Deng, U. Bierfreund, K. Sandhoff, and R.L. Proia A vital role for glycosphingolipid synthesis during development and differentiation Proc. Natl. Acad. Sci. U. S. A. 96 1999 9142 9147 (Pubitemid 29374721)
193. R. Jennemann, U. Rothermel, S. Wang, R. Sandhoff, S. Kaden, R. Out, T.J. van Berkel, J.M. Aerts, K. Ghauharali, C. Sticht, and H.J. Gröne Hepatic glycosphingolipid deficiency and liver function in mice Hepatology 51 2010 1799 1809
194. R. Jennemann, R. Sandhoff, L. Langbein, S. Kaden, U. Rothermel, H. Gallala, K. Sandhoff, H. Wiegandt, and H.J. Gröne Integrity and barrier function of the epidermis critically depend on glucosylceramide synthesis J. Biol. Chem. 282 2007 3083 3094 (Pubitemid 47084363)
195. R. Jennemann, R. Sandhoff, S. Wang, E. Kiss, N. Gretz, C. Zuliani, A. Martin-Villalba, R. Jäger, H. Schorle, M. Kenzelmann, M. Bonrouhi, H. Wiegandt, and H.J. Gröne Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth Proc. Natl. Acad. Sci. U. S. A. 102 2005 12459 12464 (Pubitemid 41266381)
196. K. Takamiya, A. Yamamoto, K. Furukawa, S. Yamashiro, M. Shin, M. Okada, S. Fukumoto, M. Haraguchi, N. Takeda, K. Fujimura, M. Sakae, M. Kishikawa, H. Shiku, K. Furukawa, and S. Aizawa Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system Proc. Natl. Acad. Sci. U. S. A. 93 1996 10662 10667 (Pubitemid 26333045)
197. H. Kawai, M.L. Allende, R. Wada, M. Kono, K. Sango, C. Deng, T. Miyakawa, J.N. Crawley, N. Werth, U. Bierfreund, K. Sandhoff, and R.L. Proia Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures J. Biol. Chem. 276 2001 6885 6888
198. M. Okada, M. Itoh Mi, M. Haraguchi, T. Okajima, M. Inoue, H. Oishi, Y. Matsuda, T. Iwamoto, T. Kawano, S. Fukumoto, H. Miyazaki, K. Furukawa, S. Aizawa, and K. Furukawa b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve J. Biol. Chem. 277 2002 1633 1636 (Pubitemid 34968730)
199. T. Yamashita, A. Hashiramoto, M. Haluzik, H. Mizukami, S. Beck, A. Norton, M. Kono, S. Tsuji, J.L. Daniotti, N. Werth, R. Sandhoff, K. Sandhoff, and R.L. Proia Enhanced insulin sensitivity in mice lacking ganglioside GM3 Proc. Natl. Acad. Sci. U. S. A. 100 2003 3445 3449 (Pubitemid 36356603)
200. M. Inoue, Y. Fujii, K. Furukawa, M. Okada, K. Okumura, T. Hayakawa, K. Furukawa, and Y. Sugiura Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside J. Biol. Chem. 277 2002 29881 29888
201. T. Yamashita, Y.P. Wu, R. Sandhoff, N. Werth, H. Mizukami, J.M. Ellis, J.L. Dupree, R. Geyer, K. Sandhoff, and R.L. Proia Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions Proc. Natl. Acad. Sci. U. S. A. 102 2005 2725 2730 (Pubitemid 40299860)